Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
05/2005
05/05/2005US20050095238 Treating a disease associated with leukocyte infiltration of mucosal tissues, such as inflammatory bowel disease, asthma, graft vs host disease, pancreatitis, diabetes, or sinutitis with a humanized immunoglobulin or antigen-binding fragment thereof having binding specificity for alpha 4 beta 7 integrin
05/05/2005US20050095224 Compositions and method for treating hepatitis virus infection
05/04/2005EP1528066A1 Aryl 5-thio-d-glucopyranoside derivatives and remedies for diabetes containing the same
05/04/2005EP1528061A1 Heterocyclic derivatives which inhibit factor Xa
05/04/2005EP1528058A1 Polymorphic crystalline forms of celecoxib
05/04/2005EP1528057A1 Nonnucleoside inhibitors of reverse transcriptase for the treatment of HIV infection
05/04/2005EP1527787A1 Immediate release tablet
05/04/2005EP1527778A1 Methods of enhancing opiate analgesic potency or detoxifying an opiate addict
05/04/2005EP1527777A1 Composition with antioxidant properties comprising an ester of ascorbic acid and a benzoyl rest
05/04/2005EP1527773A1 Pharmaceutical composition comprising sumatriptan
05/04/2005EP1527343A2 Organic compounds
05/04/2005EP1527196A2 Treatment for asthma or allergies
05/04/2005EP1527189A2 Mutant proteinase inhibitors and uses thereof
05/04/2005EP1527178A2 Novel class ii cytokine receptors and uses thereof
05/04/2005EP1527100A2 Human monoclonal antibodies to interleukin-5 and methods and compositions comprising same
05/04/2005EP1527084A2 Promoters exhibiting endothelial cell specificity and methods of using same
05/04/2005EP1527081A1 Glyconjugates comprising carbohydrate epitopes, methods for theirsynthesis, and their use for the treatment or prophylaxis of cancer
05/04/2005EP1527076A1 Dihydro-dibenzo (b,e) oxepine based selective estrogen receptor modulators, compositions and methods
05/04/2005EP1527074A1 Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
05/04/2005EP1527068A2 Novel arylimidazole derivatives, preparation and therapeutic uses thereof
05/04/2005EP1527063A1 The 9, 11-cycloendoperoxide pro-drugs of prostaglandin analogues for treatment of ocular hypertension and glaucoma
05/04/2005EP1527062A1 Tetrahydropyran derivatives and their use as therapeutic agents
05/04/2005EP1527051A1 Pyrimidyl sulphone amide derivatives as chemokine receptor modulators
05/04/2005EP1527048A2 N- phenyl(piperidin-2-yl)methyl]benzamide derivatives, preparation thereof, and use thereof in therapy
05/04/2005EP1527047A1 3-z- 1-(4-(n-((4-methyl-piperazin-1-yl)-methylcarbonyl)-n-me thyl-amino)-anilino)-1-phenyl-methylene -6-methoxycarbonyl-2 -indolinone-monoethanesulphonate and the use thereof as a pharmaceutical composition
05/04/2005EP1527046A1 Indoline derivatives substituted in position 6, production and use thereof as medicaments
05/04/2005EP1526895A2 Methods for treating carbonic anhydrase mediated disorders
05/04/2005EP1526870A1 Novel combination of glucocorticoids and pde-4-inhibitors for treating respiratory diseases, allergic diseases, asthma and copd
05/04/2005EP1526869A1 Compositions of a cyclooxygenase-2 selective inhibitor and a carbonic anhydrase inhibitor for the treatment of neoplasia
05/04/2005EP1526863A2 Using heat shock proteins to increase immune response
05/04/2005EP1526862A1 Simmondsin for use as an angiogenesis inhibitor
05/04/2005EP1526860A2 Bioavailability/bioefficacy enhancing activity of cuminum cyminum and extracts and fractions thereof
05/04/2005EP1526854A1 4-4(methylpiperazin-1-ylmethyl)-n- 4-methyl-3-(pyridin-3-yl)pyrimidin-2-ylamino)phenyl -benzamide for treating mutated-ret kinase associated diseases
05/04/2005EP1526852A1 Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
05/04/2005EP1526851A2 Compounds useful for the treatment of diseases responsive to antiangiogenetic therapy
05/04/2005EP1526847A2 Pharmaceutical dosage form comprising a sulfite compound
05/04/2005EP1526846A2 Gelatin capsule exhibiting reduced cross-linking
05/04/2005EP1526845A2 Pharmaceutical dosage form capable of maintaining stable dissolution profile upon storage
05/04/2005EP1526844A2 Pellicle-resistant gelatin capsule
05/04/2005EP1465504B1 Matrix-forming composition containing pectin
05/04/2005EP1448553B1 N-heterocyclyl hydrazides as neurotrophic agents
05/04/2005EP1446399B1 Piperazine derivatives having sst1 antagonistic activity
05/04/2005EP1442022A4 Polyamide modulators of cox2 transcription
05/04/2005EP1411881B1 5ht2c receptor modulators
05/04/2005EP1404663B1 Eurotinone and derivatives thereof, method for the production and use of the same
05/04/2005EP1395582B1 Novel piperidinecarboxamide derivatives, method for preparing same and pharmaceutical compositions containing same
05/04/2005EP1362048B1 Triazolo compounds as mmp inhibitors
05/04/2005EP1341539B1 Anti-inflammatory agents
05/04/2005EP1317448B1 Pyrazole compounds useful as protein kinase inhibitors
05/04/2005EP1307471B1 16alpha-methyl or ethyl substituted estrogens
05/04/2005EP1255546B1 Method for improving bone modeling and chondrocyte functioning in growing canines
05/04/2005EP1240165B1 N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]-carboxamide inhibitors of cyclin dependent kinases
05/04/2005EP1225895B1 Fab i inhibitors
05/04/2005EP1221480B1 Polypeptide humanin inhibiting nerve cell death
05/04/2005EP1147103B1 Phenantrhridine-n-oxides with pde-iv inhibiting activity
05/04/2005EP1140830B1 Arylpiperidine and aryl-1,2,5,6-tetrahydropyridine amide derivatives having 5ht1a receptor activity
05/04/2005EP1139752B1 Methods and compositions for treatment of cell proliferative disorders
05/04/2005EP1124810B1 2-amino-thiazole derivatives, process for their preparation, and their use as antitumor agents
05/04/2005EP1023067B1 The use of inhibitors of the renin-angiotensin system for the treatment of hypoxia or impaired metabolic function
05/04/2005EP0973529B1 Essential oil composition
05/04/2005EP0966969B1 Anti-stress drugs and functional foods having anti-stress effects
05/04/2005EP0946177B1 METHOD OF INHIBITING BIOSYNTHESIS OF EIf5A
05/04/2005EP0886637B9 Inhibitors of microsomal triglyceride transfer protein and method
05/04/2005EP0815099B1 Tricyclic amide compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
05/04/2005CN1612893A VEGF peptides and their use for inhibiting angiogenesis
05/04/2005CN1612892A Novel peptide having angiotensin convertase inhibitory effect
05/04/2005CN1612877A Spiroazacyclic compounds as monoamine receptor modulators
05/04/2005CN1612869A Novel 1, 2, 4-thiadiazolium derivatives as melanocortin receptor modulators
05/04/2005CN1612864A Novel alkansulfonamides as endothelin antagonists
05/04/2005CN1612859A Crystalline (r-(r*, r*))-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-1h-pyrrole-heptanoic acid calcium salt (2:1)
05/04/2005CN1612856A 1, 3-diarylprop-2-en-1-ones, compositions containing same and use thereof
05/04/2005CN1612751A Combination treatments for allergic disease comprising administering an anti-IgE antibody and antiallergic compound
05/04/2005CN1612746A Use of HEPCIDIN as a regulator of iron homeostasis
05/04/2005CN1612745A Methods for slowing senescence and treating and preventing diseases associated with senescence
05/04/2005CN1612743A Herbal composition phy906 and its use in chemotheraphy
05/04/2005CN1612736A Imidazo (4, 3-e)-1, 2, 4-triazolo(1, 5-c) pyrimidines as adenosine A2A receptor antagonists
05/04/2005CN1612734A Aqueous liquid preparations and light-stabilized aqueous liquid preparations
05/04/2005CN1612733A Benzimidazoles useful as protein kinase inhibitors
05/04/2005CN1612731A Composition inhibiting matrix-metallproteinases for the treatmentof neoplastic diseases
05/04/2005CN1612729A 2-aryl-propionic acid and medicine composition containing same
05/04/2005CN1612725A Injectable depot composition
05/04/2005CN1612691A Methods and compositions for correction of cardiac conduction disturbances
05/04/2005CN1611499A Heterocyclic compounds as inhibitors of rotamase enzymes
05/04/2005CN1611249A Antisenescent longevity powder
05/04/2005CN1611232A Medicinal composition with main effect of antifatigue, radioresistance and melancholia-resistance and its preparing method
05/04/2005CN1611229A Full-solved encrinite pollen and its antistress function
05/04/2005CN1611228A Full-solved fordia and its antistress function
05/04/2005CN1200000C Cyclie somatostatin analogs
05/04/2005CN1199971C Quaternary ammonium compounds as tachykinin antagonists
05/04/2005CN1199959C Percyquuinnin, process for its production and its use pharmaceutical
05/04/2005CN1199954C Benzodiazepine derivatives
05/04/2005CN1199950C Quinolene derivatives as anti-inflammation agents
05/04/2005CN1199689C Hemoglobin polymerizing agent
05/04/2005CN1199652C Medicine for treating by-effect caused by chemotherapy and radiotherapy, and producing method thereof
05/04/2005CN1199644C Medicine for treatment of accidental extravasation of anthryracyclines
05/04/2005CN1199636C Use of 15-deoxysperguallin for the treatment of hyperreactive inflammatory diseases and autoimmune diseases
05/03/2005US6888027 Carbamic acid compounds comprising a sulfonamide linkage as HDAC inhibitors
05/03/2005US6888015 Sphingolipid synthesis inhibitor
05/03/2005US6888007 Stable crystal structure; thrombin inhibitor
05/03/2005US6888001 Selective modulators of the nicotinic acetylcholine receptor useful in the treatment of pain, Alzheimer's disease, memory loss or dementia or loss of motor function.
1 ... 507 508 509 510 511 512 513 514 515 516 517 518 519 520 521 522 523 524 525 526 527 ... 1564